Crestor to reduce cardiovascular risk in some patients WITHOUT high cholesterol

March 2010

Reps will be promoting Crestor to reduce cardiovascular risk in some patients WITHOUT high cholesterol....

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology Losartan will be the first GENERIC angiotensin receptor blocker
Cardiology Crestor to reduce cardiovascular risk in some patients WITHOUT high cholesterol
Diabetes Metformin or glyburide will be used more for gestational diabetes
Diabetes Victoza (VIC-tow-za) will compete with Byetta for type 2 diabetes
Nitrates how to choose a long-acting isosorbide product
Smoking Cessation Chantix (varenicline) in patients with cardiovascular disease to help them stop smoking
Substance Use Disorder There's concern about people abusing clonidine
Ophthalmology when to worry about drug or disease interactions with beta-blocker EYEDROPS for glaucoma
Infectious Diseases appropriate antibiotics for empiric treatment of complicated intra-abdominal infections
Supplements whether saw palmetto is effective for benign prostatic hyperplasia (BPH)
health care professionals are asking how they can donate medications for an emergency
Gastroenterology Should patients stop taking low-dose aspirin after a GI bleed
Cardiology whether Avandia (rosiglitazone) increases heart attack risk
Geriatrics adjust med regimens to help avoid falls in the frail elderly